Impact of Diabetes on 90-Day Episodes of Care After Elective Total Joint Arthroplasty Among Medicare Beneficiaries
Open Access
- 22 October 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 102 (24) , 2157-2165
Abstract
Background: In an effort to improve quality and reduce costs, reimbursement for total knee arthroplasty (TKA) and total hip arthroplasty (THA) in the United States is being based on the value of care provided, with adjustments for some qualifying comorbidities, including diabetes in its most severe form and excluding many diabetes codes. The aims of this study were to examine the effects of diabetes on elective TKA or THA complications and readmission risks among Medicare beneficiaries. Methods: Complication (n = 521,230) and readmission (n = 515,691) data were extracted from Medicare files in 2013 and 2014. Diabetes status (no diabetes, controlled-uncomplicated diabetes, controlled-complicated diabetes, and uncontrolled diabetes) was identified with ICD-9 (International Classification of Diseases, 9th Revision) codes. TKA or THA complications and readmission odds based on diabetes status were estimated using logistic regression and adjusted for sociodemographic and clinical characteristics, including comorbidities. Results: Compared with no diabetes, the odds ratio (OR) of TKA complications was significantly higher for uncontrolled diabetes (1.29, 95% confidence interval [CI] = 1.06 to 1.57). The OR of THA complications was significantly higher for controlled-complicated diabetes (1.45, 95% CI = 1.17 to 1.80). The OR of readmission was significantly higher for all diabetes groups (1.21 to 1.48 for TKA, 1.20 to 1.70 for THA). Conclusions: Readmission odds were higher in all diabetes categories. The uncontrolled-diabetes group had the greatest TKA readmission and complication odds. The controlled-complicated diabetes group had the greatest THA readmission and complication odds. The findings suggest that including diabetes and associated systemic complications in cost adjustments in alternative payment models for arthroplasty should be considered. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.Keywords
This publication has 21 references indexed in Scilit:
- Complicações pós‐artroplastia total de quadril em portadores e não portadores de diabetes mellitus controlado durante a internaçãoRevista Brasileira de Ortopedia, 2016
- Should All Patients Be Included in Alternative Payment Models for Primary Total Hip Arthroplasty and Total Knee Arthroplasty?The Journal of Arthroplasty, 2016
- Severity of Diabetes Mellitus and Total Hip or Knee ReplacementMedicine, 2016
- Medicare Program; Comprehensive Care for Joint Replacement Payment Model for Acute Care Hospitals Furnishing Lower Extremity Joint Replacement Services. Final rule.2015
- Episode of Care Payments in Total Joint Arthroplasty and Cost Minimization StrategiesHSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery, 2015
- Factors affecting hospital charges after total shoulder arthroplasty: an evaluation of the National Inpatient Sample databaseJournal of Shoulder and Elbow Surgery, 2014
- Bone quality assessment in type 2 diabetes mellitusOsteoporosis International, 2014
- The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacementOsteoarthritis and Cartilage, 2011
- Indications for hip and knee replacement in SwedenJournal of Evaluation in Clinical Practice, 2010
- The Impact of Glycemic Control and Diabetes Mellitus on Perioperative Outcomes After Total Joint ArthroplastyJournal of Bone and Joint Surgery, 2009